Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension

201092 citationsJournal Article

Authors

Good health and well-being

Published in: American Journal of Ophthalmology

Volume 149, Issue 4, pp. 661-671.e1

Field-Weighted Citation Impact: 7.42